These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

907 related items for PubMed ID: 27394432

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [Abstract] [Full Text] [Related]

  • 27. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
    Tosoian JJ, Chappidi M, Feng Z, Humphreys EB, Han M, Pavlovich CP, Epstein JI, Partin AW, Trock BJ.
    BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7.
    Serkin FB, Soderdahl DW, Cullen J, Chen Y, Hernandez J.
    Urol Oncol; 2010 May; 28(3):302-7. PubMed ID: 19117774
    [Abstract] [Full Text] [Related]

  • 30. Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
    Jin BS, Kang SH, Kim DY, Oh HG, Kim CI, Moon GH, Kwon TG, Park JS.
    Korean J Urol; 2015 Sep; 56(9):624-9. PubMed ID: 26366274
    [Abstract] [Full Text] [Related]

  • 31. Downgrading of biopsy based Gleason score in prostatectomy specimens.
    Treurniet KM, Trudel D, Sykes J, Evans AJ, Finelli A, Van der Kwast TH.
    J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
    [Abstract] [Full Text] [Related]

  • 32. Elevated fatty acid synthase expression in prostate needle biopsy cores predicts upgraded Gleason score in radical prostatectomy specimens.
    Hamada S, Horiguchi A, Kuroda K, Ito K, Asano T, Miyai K, Iwaya K.
    Prostate; 2014 Jan; 74(1):90-6. PubMed ID: 24108439
    [Abstract] [Full Text] [Related]

  • 33. Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer.
    Kamrava M, Kishan AU, Margolis DJ, Huang J, Dorey F, Lieu P, Kupelian PA, Marks LS.
    Pract Radiat Oncol; 2015 Jan; 5(6):411-6. PubMed ID: 26059510
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy].
    Zuo Q, Zhang F, Huang Y, Ma LL, Lu M, Lu J.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug 18; 48(4):603-606. PubMed ID: 29263497
    [Abstract] [Full Text] [Related]

  • 36. The proportion of free PSA and upgrading of biopsy Gleason score after radical prostatectomy.
    Visapää H, Hotakainen K, Lundin J, Ala-Opas M, Stenman UH.
    Urol Int; 2010 Aug 18; 84(4):378-81. PubMed ID: 20299777
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
    Choy B, Pearce SM, Anderson BB, Shalhav AL, Zagaja G, Eggener SE, Paner GP.
    Am J Surg Pathol; 2016 Oct 18; 40(10):1400-6. PubMed ID: 27379821
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.